Irish medical device company Mainstay Medical has identified Germany as the launch market, later this year, for its breakthrough treatment for chronic back pain.

Mainstay Medical, the Dublin healthcare firm on the verge of a breakthrough in chronic back pain treatment, is considering a further round of fundraising as it prepares its main product for market.

Dublin-based medical devices firm, Mainstay Medical has received a boost to its attempts to commercialise a breakthrough treatment for chronic back pain by securing $15m (€13m) in debt financing.